VA2

General Information


DRACP ID  DRACP03525

Peptide Name   VA2

Sequence  KAXWKXVKXAK

Sequence Length  11

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antiparasitic; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Acetylation

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C46H73N13O6

Absent amino acids  CDEFGHILMNPQRSTY

Common amino acids  K

Mass  141272

Pl  11.28

Basic residues  4

Acidic residues  0

Hydrophobic residues  4

Net charge  4

Boman Index  -1221

Hydrophobicity  -79.09

Aliphatic Index  44.55

Half Life 
  /

Extinction Coefficient cystines  5500

Absorbance 280nm  550

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23876294

Title  Mechanism of action of novel Synthetic peptide dodecapeptides against Candida albicans

Doi Not available

Year  2013

Literature 2

Pubmed ID 22118799

Title  In vitro antibacterial and antimalarial activity of dehydrophenylalanine-containing undecapeptides alone and in combination with drugs

Doi Not available

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  6283

DRACP is developed by Dr.Zheng's team.